{"id":"NCT00930644","sponsor":"Shire","briefTitle":"Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)","officialTitle":"A Long-Term, Open-Label Study With Teduglutide for Subjects With Parenteral Nutrition Dependent Short Bowel Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09-21","primaryCompletion":"2013-01-24","completion":"2013-01-24","firstPosted":"2009-06-30","resultsPosted":"2014-12-24","lastUpdate":"2021-06-11"},"enrollment":88,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"teduglutide","otherNames":["Gattex"]}],"arms":[{"label":"teduglutide","type":"EXPERIMENTAL"}],"summary":"This study is a 2-year open label extension study to collect long term efficacy and safety data from patients who have completed the 24-weeks of study drug dosing in CL0600-020.","primaryOutcome":{"measure":"Percent Change in PN/IV Volume by Visit","timeFrame":"24 months","effectByArm":[{"arm":"NT/TED","deltaMin":-5.35,"sd":11.287},{"arm":"PBO/TED","deltaMin":-6.44,"sd":11.241},{"arm":"TED/TED","deltaMin":-40.65,"sd":21.546}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":23,"countries":["United States","Canada","Denmark","France","Germany","Italy","Poland","Spain","United Kingdom"]},"refs":{"pmids":["16099790","32341691"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":51},"commonTop":["Infections and Infestations","Gastrointestinal Disorders","General Disorders, and Administration Site Conditions","Investigations","Injury, Poisoning, and Procedural Complications"]}}